Clinical Trial Update: Study of Patient With Frequent Exacerbations in Moscow

View source ↗

Summary

AstraZeneca is conducting a clinical trial in Moscow to study COPD patients with frequent exacerbations; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Status: RECRUITING